A self-amplifying RNA vector based on rubella virus for mRNA therapeutics and vaccine applications. [PDF]
Jing M +6 more
europepmc +1 more source
Genetically predicted anti‑rubella virus IgG levels and dermatitis risk: A two‑sample Mendelian randomization study. [PDF]
Ouyang Z +5 more
europepmc +1 more source
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis. [PDF]
Ingvarsson J +12 more
europepmc +1 more source
Fatal Systemic Granulomatous Disease Associated with Vaccine-Derived Rubella Virus in AIOLOS-Associated Immunodeficiency. [PDF]
Zhou L +15 more
europepmc +1 more source
Rubella virus-associated necrotizing granulomatous inflammation with extensive eyelid, ocular, and orbital involvement. [PDF]
Pimentel MA +14 more
europepmc +1 more source
Rubella Virus-Associated Granulomas in Immunocompetent Adults-Possible Implications. [PDF]
Notarangelo LD.
europepmc +1 more source
Evaluation of Commercial Immunoassays for Rubella Virus IgG Detection in Low-Antibody Sera Using a Recombinant Immunoblot as a Reference Method. [PDF]
Ortega C +9 more
europepmc +1 more source
Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, Hepatitis C Virus, HIV, Syphilis, and <i>Toxoplasma gondii</i> Antibodies in Pregnant Women. [PDF]
Akıllı FM, Demir F, Onat T.
europepmc +1 more source
Rubella virus mutations that confer resistance to inactivation at low pH. [PDF]
Das PK, Kielian M.
europepmc +1 more source

